Clinical Trial Update: A Study of Amphotericin B Liposome for Injection in Patients With Persistent Neutropenia and Fever [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for amphotericin B liposome in patients with persistent neutropenia and fever.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fever
• Neutropenia

Drugs mentioned

• Amphotericin B Liposome for Injection (amphotericin B liposome)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Neutropenia and Fever | Phase 3 | Status: UNKNOWN